A group of 29 international experts says that simultaneous screening for hypertension and heart arrhythmia could prevent ...

The company is first rolling out the use of the Volt system among European Union doctors who have already gained experience ...

While several effective treatment options for AFib exist, current evidence strongly suggests that pulsed field ablation (PFA) ...

The Volt PFA system. [Image courtesy of Abbott] Abbott (NYSE: ABT) + announced it received CE mark approval in Europe for its ...

Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has ...

Applications are now being accepted for Future Docs, a leadership program of the Chattanooga-Hamilton County Medical Society ...

A New Pacemaker Algorithm for the Treatment of Atrial Fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT) Electrophysiologic Characteristics of the Spontaneous Onset and ...

Atrial Fibrillation (Afib) is a common, yet serious heart condition that requires proper diagnosis and management strategies.

Though late to the party compared to other industry leaders, Abbott joins a pulsed field ablation market poised for ...

Cardiac electrophysiologist Dr. Jonathan Piccini says Medtronic's Define AFib study offers important lessons for other device ...

Thursday announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation (AFib).

Abbott's Volt PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillationPulsed field ablation - or PFA - uses high energy electrical ...